MENU
+Compare
IGC
Stock ticker: ASE
AS OF
Nov 13, 04:59 PM (EDT)
Price
$0.35
Change
-$0.02 (-5.41%)
Capitalization
32.74M

IGC IGC Pharma Forecast, Technical & Fundamental Analysis

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer’s disease, period cramps, premenstrual syndrome, and chronic pain... Show more

Industry: #Biotechnology
IGC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for IGC with price predictions
Nov 12, 2025

IGC in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 22, 2025

IGC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 38 cases where IGC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 78 cases where IGC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IGC advanced for three days, in of 232 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IGC as a result. In of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IGC turned negative on November 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .

IGC moved below its 50-day moving average on October 29, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IGC crossed bearishly below the 50-day moving average on October 22, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IGC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IGC entered a downward trend on October 31, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.385) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (21.231) is also within normal values, averaging (322.723).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IGC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IGC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
IGC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

IGC is expected to report earnings to -1 cents per share on November 17

IGC Pharma IGC Stock Earnings Reports
Q3'25
Est.
$-0.02
Q2'25
Beat
by $0.01
Q1'25
Est.
$-0.02
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.01
The last earnings report on August 19 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 572.54K shares outstanding, the current market capitalization sits at 32.74M.
A.I. Advisor
published General Information

General Information

a company, which engages in focuses on developing and commercializing a portfolio of cannabinoid based biopharmaceutical therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10224 Falls Road
Phone
+1 301 983-0998
Employees
61
Web
https://www.igcinc.us
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBVA21.830.38
+1.77%
Banco Bilbao Vizcaya Argentaria SA
OLED120.921.55
+1.30%
Universal Display Corp
BRY3.40-0.04
-1.16%
Berry Corp
RES5.50-0.18
-3.17%
RPC
BEEM1.86-0.28
-13.08%
Beam Global

IGC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IGC has been loosely correlated with TECX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IGC jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
-5.35%
TECX - IGC
49%
Loosely correlated
-0.63%
ANVS - IGC
30%
Poorly correlated
+15.17%
ARTL - IGC
29%
Poorly correlated
-8.16%
KZR - IGC
28%
Poorly correlated
-0.32%
CRBU - IGC
28%
Poorly correlated
+0.89%
More